Insider screener

Period: 12 months + Add filter
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

59,448 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

59,448 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

59,448 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

59,448 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
59,448 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
59,448 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

59,448 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
7 Jan 2026
Ajay K Puri EVP, Worldwide Field Ops · indirect
Sold on a plan 3×
$37.56M 200,000 at 187.82
5.0%
Planned (10b5-1)
7 Jan 2026
Sasan K Goodarzi CEO, President and Director · indirect
Sold on a plan 2×
$26.65M 41,000 at 650.10
75.1%
Sold half or more
7 Jan 2026
Caroline Cochran Co-Founder, COO · indirect
Sold on a plan 9×
$22.99M 231,658 at 99.25
21.7%
Planned (10b5-1)
7 Jan 2026
Jacob DeWitte Co-Founder, CEO · indirect
Sold on a plan 9×
$22.99M 231,657 at 99.25
21.9%
Planned (10b5-1)
7 Jan 2026
Bought on a plan 2×
$18.15M 265,000 at 68.50
0.5%
Bought on a plan
7 Jan 2026
Brian M Venturo Chief Strategy Officer · indirect
Sold on a plan 4×
$12.07M 154,479 at 78.11
100%
Sold half or more
7 Jan 2026
Matthew Prince CEO & Board Co-Chair · indirect
Sold on a plan 7×
$10.57M 52,384 at 201.84
100%
Sold half or more
7 Jan 2026
Sundar Pichai Chief Executive Officer
Sold on a plan 11×
$10.44M 32,500 at 321.21
1.4%
Planned (10b5-1)
7 Jan 2026
Jacob DeWitte Co-Founder, CEO
Sold on a plan 7×
$9.02M 92,005 at 98.03
9.9%
Planned (10b5-1)
7 Jan 2026
Caroline Cochran Co-Founder, COO
Sold on a plan 7×
$9.02M 92,004 at 98.03
10.0%
Planned (10b5-1)
7 Jan 2026
Ae Red Holdings, LLC Director · indirect
Sold at will
$8.80M 872,599 at 10.08
1.0%
Not planned
7 Jan 2026
Margaret A Horn Chief Operating Officer
Sold on a plan 3×
$7.54M 75,000 at 100.56
34.7%
Planned (10b5-1)
7 Jan 2026
Benjamin Seong Lee Chief Legal Officer
Sold on a plan 2×
$7.26M 27,930 at 260.08
30.8%
Planned (10b5-1)
7 Jan 2026
Patrick W Smith Chief Executive Officer
Sold on a plan 14×
$6.19M 10,000 at 619.01
0.3%
Planned (10b5-1)
7 Jan 2026
Scilex Holding Co 10% owner
Sold at will
$5.81M 4,835,581 at 1.20
2.0%
Not planned
7 Jan 2026
Herriot Tabuteau Chief Executive Officer
Sold on a plan
$5.33M 31,261 at 170.38
81.2%
Sold half or more
7 Jan 2026
David Baszucki President & CEO · indirect
Sold on a plan 6×
$5.12M 66,896 at 76.48
100%
Sold half or more
7 Jan 2026
Suren Gupta President,Enterprise Solutions
Sold on a plan
$4.11M 19,593 at 210.00
16.3%
Planned (10b5-1)
7 Jan 2026
Shannon L. Devers EVP, Chief Human Resources Ofc
Sold on a plan 5×
$3.76M 44,199 at 85.08
71.6%
Sold half or more
7 Jan 2026
Berkshire Hathaway Inc 10% owner · indirect
Sold at will
$3.58M 44,100 at 81.22
0.4%
Not planned
7 Jan 2026
Sold at will
$3.34M 741,272 at 4.50
22.2%
Not planned
7 Jan 2026
Ishbia Mat President and CEO · indirect
Sold on a plan
$2.97M 632,874 at 4.70
12.5%
Planned (10b5-1)
7 Jan 2026
Sold on a plan
$2.25M 72,337 at 31.16
100%
Sold half or more
7 Jan 2026
Ourania Tatsis EVP, Chief Reg. & Quality Off.
Sold on a plan
$2.14M 4,500 at 474.99
9.6%
Planned (10b5-1)
7 Jan 2026
David Abraham Gilboa Co-Chief Executive Officer
Sold on a plan
$2.03M 75,000 at 27.09
66.8%
Sold half or more
7 Jan 2026
Bruce Chung EVP & CFO
Sold on a plan 2×
$1.94M 12,383 at 156.56
13.5%
Planned (10b5-1)
7 Jan 2026
Jonathan M Rothberg Director · indirect
Sold on a plan
$1.87M 452,729 at 4.14
57.4%
Sold half or more
7 Jan 2026
James H. Litinsky Chairman and CEO · indirect
Sold on a plan
$1.75M 27,400 at 64.01
0.2%
Planned (10b5-1)
7 Jan 2026
Malynda K West President & CEO
Sold on a plan
$1.72M 4,051 at 425.00
3.3%
Planned (10b5-1)
7 Jan 2026
Ben Haim Shlomi Chief Executive Officer
Sold on a plan
$1.49M 25,000 at 59.66
0.5%
Planned (10b5-1)
7 Jan 2026
Bought
$1.46M 66,467 at 22.00
0.4%
7 Jan 2026
Carl Dambkowski Chief Medical Officer
Sold on a plan 4×
$1.46M 18,700 at 77.84
8.1%
Planned (10b5-1)
7 Jan 2026
William Joseph Brennan Pres & Chief Executive Officer
Sold on a plan 18×
$1.41M 10,456 at 135.03
3.6%
Planned (10b5-1)
7 Jan 2026
Neil Harris Blumenthal Co-Chief Executive Officer
Sold on a plan
$1.35M 50,000 at 27.08
57.4%
Sold half or more
7 Jan 2026
Sold at will
$1.31M 4,000 at 328.34
33.8%
Not planned
7 Jan 2026
Kevin Krumm Chief Financial Officer
Sold at will 2×
$1.31M 21,406 at 61.23
13.0%
Not planned
7 Jan 2026
Michael J. Farrell Chairman and CEO
Sold on a plan
$1.24M 4,991 at 248.46
1.1%
Planned (10b5-1)
7 Jan 2026
Scott Farquhar Director · indirect
Sold on a plan 7×
$1.23M 7,665 at 161.11
1.7%
Planned (10b5-1)
7 Jan 2026
Michael Cannon-Brookes CEO, Co-Founder · indirect
Sold on a plan 7×
$1.23M 7,665 at 161.11
1.7%
Planned (10b5-1)
7 Jan 2026
Russell Wayne Ford Chief Executive Officer · indirect
Sold on a plan
$1.21M 40,000 at 30.24
4.3%
Planned (10b5-1)
7 Jan 2026
Sold on a plan
$1.20M 99,986 at 12.03
28.6%
Planned (10b5-1)
7 Jan 2026
Bonnie L Bassler Director
Sold on a plan
$1.20M 1,500 at 800.00
46.8%
Planned (10b5-1)
7 Jan 2026
Mohamed Khairie Issa EVP, Head of US Oncology
Sold on a plan
$1.18M 10,856 at 109.07
14.1%
Planned (10b5-1)
7 Jan 2026
Vladimir Galkin 10% owner
Sold at will
$1.15M 643,505 at 1.79
100%
Sold half or more
7 Jan 2026
Terilyn J. Monroe Chief People Officer
Sold on a plan 3×
$1.12M 10,031 at 112.08
32.3%
Planned (10b5-1)
7 Jan 2026
Sold at will
$1.05M 26,920 at 39.11
100%
Sold half or more
7 Jan 2026
Mark D. McClain Chief Executive Officer
Sold on a plan
$1.03M 51,986 at 19.90
0.7%
Planned (10b5-1)
7 Jan 2026
Harold Bernstein President, R&D & CMO
Sold on a plan
$1.01M 25,156 at 40.20
100%
Sold half or more
Showing 48,101–48,150 of 59,448. ← Newer Page 963 of 1,189 Older →